These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34040529)

  • 1. Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations.
    Costa RF; Turones LC; Cavalcante KVN; Rosa Júnior IA; Xavier CH; Rosseto LP; Napolitano HB; Castro PFDS; Neto MLF; Galvão GM; Menegatti R; Pedrino GR; Costa EA; Martins JLR; Fajemiroye JO
    Front Pharmacol; 2021; 12():666725. PubMed ID: 34040529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Outlook of Pyrazole Analogs: A Mini Review.
    Ganguly S; Jacob SK
    Mini Rev Med Chem; 2017; 17(11):959-983. PubMed ID: 26586126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
    Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic voyage of pyrazole and its analogs: A review.
    Khan MF; Alam MM; Verma G; Akhtar W; Akhter M; Shaquiquzzaman M
    Eur J Med Chem; 2016 Sep; 120():170-201. PubMed ID: 27191614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pyrazole derivatives in the management of inflammation.
    Turones LC; Martins AN; Moreira LKDS; Fajemiroye JO; Costa EA
    Fundam Clin Pharmacol; 2021 Apr; 35(2):217-234. PubMed ID: 33171533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial Agents.
    Karati D; Mahadik KR; Trivedi P; Kumar D
    Med Chem; 2022; 18(10):1044-1059. PubMed ID: 35240964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazole Scaffolds Having Promising Pharmacological Potential: A Review.
    Singh S; Tehlan S; Kumar Verma P
    Mini Rev Med Chem; 2023; 23(22):2142-2165. PubMed ID: 36959145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole Scaffolds: Centrality in Anti-Inflammatory and Antiviral Drug Design.
    Karati D; Mahadik KR; Kumar D
    Med Chem; 2022; 18(10):1060-1072. PubMed ID: 35410619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential.
    Kumari P; Agrawal N; Mujwar S
    Med Chem; 2024; 20(8):799-817. PubMed ID: 38757317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line.
    Bennani FE; Doudach L; Cherrah Y; Ramli Y; Karrouchi K; Ansar M; Faouzi MEA
    Bioorg Chem; 2020 Apr; 97():103470. PubMed ID: 32120072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013).
    Li M; Zhao BX
    Eur J Med Chem; 2014 Oct; 85():311-40. PubMed ID: 25104650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.
    Karrouchi K; Radi S; Ramli Y; Taoufik J; Mabkhot YN; Al-Aizari FA; Ansar M
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29329257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents.
    Liu JJ; Zhao MY; Zhang X; Zhao X; Zhu HL
    Mini Rev Med Chem; 2013 Nov; 13(13):1957-66. PubMed ID: 23937232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Pyrazole-based Protein Kinase Inhibitors as Emerging Therapeutic Targets.
    Cetin A
    Comb Chem High Throughput Screen; 2023 Nov; ():. PubMed ID: 37946345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in bioactive pyrazoles.
    Küçükgüzel ŞG; Şenkardeş S
    Eur J Med Chem; 2015 Jun; 97():786-815. PubMed ID: 25555743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazole-based and N,N-diethylcarbamate functionalized some novel aurone analogs: Design, synthesis, cytotoxic evaluation, docking and SAR studies, against AGS cancer cell line.
    Lathwal E; Kumar S; Sahoo PK; Ghosh S; Mahata S; Nasare VD; Kapavarapu R; Kumar S
    Heliyon; 2024 Mar; 10(5):e26843. PubMed ID: 38463825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of the Role of In silico Methods in Pyrazole Based Drug Design.
    Sharma S; Bhatia V
    Mini Rev Med Chem; 2021; 21(2):204-216. PubMed ID: 32875985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives.
    Ebenezer O; Shapi M; Tuszynski JA
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive, anti-inflammatory and antipyretic effects of 1.5-diphenyl-1H-Pyrazole-3-carbohydrazide, a new heterocyclic pyrazole derivative.
    Malvar Ddo C; Ferreira RT; de Castro RA; de Castro LL; Freitas AC; Costa EA; Florentino IF; Mafra JC; de Souza GE; Vanderlinde FA
    Life Sci; 2014 Jan; 95(2):81-8. PubMed ID: 24355293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.